Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Which AML Subsets Benefit from Leukemic Cell Priming during Chemotherapy?

April 26, 2017acute myeloid leukemia AML benefit CELL chemotherapy leukemic priming subsets

0

Posted

Which AML Subsets Benefit from Leukemic Cell Priming during Chemotherapy?

1 Answer

0

Posted

Long-Term Analysis of the ALFA-9802 GM-CSF Study Tuesday, December 9, 2008: 8:00 AM 3020-3022-3024 – West (Moscone Center) Xavier Thomas1*, Emmanuel Raffoux2*, Aline Renneville3*, C.cile Pautas, MD4*, Stephane de Botton5*, Thierry de Revel6*, Oumedaly Reman7*, Christine Terre8*, Claude Gardin9*, Quoc-Hung Le10*, Nathalie Philippe3*, Catherine Cordonnier, MD11, Jean-Henri Bourhis12*, Mohamed Elhamri13*, Sandrine Hayette14*, Christine Parmentier2*, Pierre Fenaux15, Sylvie Castaigne, MD16, Claude Preudhomme, PhD17 and Herv Dombret181Hematologie, Hpital Edouard Herriot, Lyon, France 2Dept. of Hematology, Hopital Saint Louis, Paris, France 3Hematology, Claude Huriez Hospital, Lille, France 4Hematology, Henri Mondor University Hospital, 94000 Creteil, France 5Groupe Francophone des Myelodysplasies (GFM), Bobigny, France 6Percy Clamart, Clamart, France 7CHU Caen, Caen, France 8CH de Versailles 9Avicenne Hospital, Bobigny, France 10Hematology, Edouard Herriot Hospital, Lyon, France 11Hematolog